EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug-induced hyponatremia in clinical care

Buster Mannheimer, Jonatan D Lindh, Cecilia Bergh Fahlén, Issa Issa, Henrik Falhammar, Jakob Skov

European Journal of Internal Medicine · 2025

DOI: 10.1016/j.ejim.2025.04.034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Internal Medicine, 2025. Verfasst von Buster Mannheimer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science and Education at Södersjukhuset, Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Södersjukhuset, Sto…. Hauptthemen laut MEDLINE: Hyponatremia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tore Nilson Foundation for Medical Research, Karolinska Institutet, Stockholms Läns Landsting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Over the last decades, advances in understanding of previously described associations have important implications for diagnosis and workup of hyponatremia. In addition, new drug groups potentially affecting sodium balance and water homeostasis have evolved. The aim of this review is to summarize current evidence on drug-induced hyponatremia in clinical care. METHODS: We searched PubMed using the string "Inappropriate ADH Syndrome/chemically induced"[Mesh] OR "Inappropriate ADH Syndrome/diagnosis"[Mesh]) OR ("Hyponatremia/chemically induced"[Mesh] OR "Hyponatremia/diagnosis"[Mesh]), January 1st, 2008, to September 2nd 2024. In total 2003 articles were found and reviewed. Relevant articles referenced herein were subsequently traced backwards and also reviewed. RESULTS: Drugs associated with hyponatremia, including selective serotonin reuptake inhibitors, antipsychotics, antiepileptic drugs and proton pump inhibitors, typically cause hyponatremia shortly after initiation of treatment. For thiazide diuretics, the number one culprit in drug-induced hyponatremia, the risk for hyponatremia is highest the first weeks after initiation and then gradually decreases to a stable but still increased level after around 3 months. Several drugs that promote a negative water balance such as loop diuretics, lithium and of sodium-glucose cotransporter-2 inhibitors appear to decrease the risk for hyponatremia. Treatment with immune checkpoint inhibitors is associated with an increased risk of hypophysitis and adrenalitis resulting in hyponatremia due to secondary and primary cortisol deficiency. CONCLUSION: For most drugs associated with hyponatremia, including thiazides, the cause-effect relationship is tightly linked to newly initiated treatment. Further research is warranted to characterize the association between hyponatremia and newly developed drugs such as sodium-glucose cotransporter-2 inhibitors and immune checkpoint inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyponatremiaHumansAntipsychotic AgentsInappropriate ADH SyndromeProton Pump InhibitorsAnticonvulsantsSelective Serotonin Reuptake Inhibitors

Stichwörter der Autor:innen

Adverse reactionChemically inducedDysnatremiaSIAD

Substanzen

Antipsychotic AgentsProton Pump InhibitorsAnticonvulsantsSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Science and Education at Södersjukhuset, Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Södersjukhuset, Stockholm, Sweden. Electronic address: buster.mannheimer@ki.se.
  • Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Science and Education at Södersjukhuset, Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Södersjukhuset, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Karlstad Central Hospital, Region Värmland, Sweden.

Förderung

  • Tore Nilson Foundation for Medical Research
  • Karolinska Institutet
  • Stockholms Läns Landsting

Zitieren

APA

Mannheimer, B., Lindh, J. D., Fahlén, C. B., Issa, I., Falhammar, H., & Skov, J. (2025). Drug-induced hyponatremia in clinical care. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2025.04.034

Vancouver

Mannheimer B, Lindh JD, Fahlén CB, Issa I, Falhammar H, Skov J. Drug-induced hyponatremia in clinical care. European Journal of Internal Medicine. 2025. doi:10.1016/j.ejim.2025.04.034

BibTeX
@article{Mannheimer2025,
  author = {Mannheimer, Buster and Lindh, Jonatan D and Fahlén, Cecilia Bergh and Issa, Issa and Falhammar, Henrik and Skov, Jakob},
  title = {Drug-induced hyponatremia in clinical care},
  journal = {European Journal of Internal Medicine},
  year = {2025},
  doi = {10.1016/j.ejim.2025.04.034}
}
Kostenlos starten →